世界の食道がん治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Esophageal Cancer Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5728 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、食道がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他）、用途別市場規模（標的療法、化学療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・食道がん治療薬の市場動向 ・企業の競争状況、市場シェア ・食道がん治療薬の種類別市場規模と予測2016-2027（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他） ・食道がん治療薬の用途別市場規模と予測2016-2027（標的療法、化学療法） ・食道がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・食道がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・食道がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・食道がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・食道がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd、Merck & Co., Inc.、Sanofi） ・結論

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes (“glands”) around the collarbone, a dry cough, and possibly coughing up or vomiting blood.
Various combinations of drugs such as fluorouracil, cisplatin, docetaxel, and carboplatin are involved in standard chemotherapy regimens for the treatment of esophageal cancer. These drugs are selected based on adverse drug reactions and cancer subtypes. To ensure patient access to available therapeutics, governments in developed countries are introducing reimbursement policies.

Market Analysis and Insights: Global Esophageal Cancer Drugs Market
The global Esophageal Cancer Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Esophageal Cancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Esophageal Cancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Esophageal Cancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Esophageal Cancer Drugs market.

Global Esophageal Cancer Drugs Scope and Market Size
Esophageal Cancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Esophageal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fluorouracil
Cisplatin
Docetaxel
Carboplatin
Others

Segment by Application
Targeted Therapy
Chemotherapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Esophageal Cancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluorouracil
1.2.3 Cisplatin
1.2.4 Docetaxel
1.2.5 Carboplatin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Esophageal Cancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Esophageal Cancer Drugs Market Perspective (2016-2027)
2.2 Esophageal Cancer Drugs Growth Trends by Regions
2.2.1 Esophageal Cancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Esophageal Cancer Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Esophageal Cancer Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Esophageal Cancer Drugs Industry Dynamic
2.3.1 Esophageal Cancer Drugs Market Trends
2.3.2 Esophageal Cancer Drugs Market Drivers
2.3.3 Esophageal Cancer Drugs Market Challenges
2.3.4 Esophageal Cancer Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Esophageal Cancer Drugs Players by Revenue
3.1.1 Global Top Esophageal Cancer Drugs Players by Revenue (2016-2021)
3.1.2 Global Esophageal Cancer Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Esophageal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Esophageal Cancer Drugs Revenue
3.4 Global Esophageal Cancer Drugs Market Concentration Ratio
3.4.1 Global Esophageal Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Esophageal Cancer Drugs Revenue in 2020
3.5 Esophageal Cancer Drugs Key Players Head office and Area Served
3.6 Key Players Esophageal Cancer Drugs Product Solution and Service
3.7 Date of Enter into Esophageal Cancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Esophageal Cancer Drugs Breakdown Data by Type
4.1 Global Esophageal Cancer Drugs Historic Market Size by Type (2016-2021)
4.2 Global Esophageal Cancer Drugs Forecasted Market Size by Type (2022-2027)

5 Esophageal Cancer Drugs Breakdown Data by Application
5.1 Global Esophageal Cancer Drugs Historic Market Size by Application (2016-2021)
5.2 Global Esophageal Cancer Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Esophageal Cancer Drugs Market Size (2016-2027)
6.2 North America Esophageal Cancer Drugs Market Size by Type
6.2.1 North America Esophageal Cancer Drugs Market Size by Type (2016-2021)
6.2.2 North America Esophageal Cancer Drugs Market Size by Type (2022-2027)
6.2.3 North America Esophageal Cancer Drugs Market Size by Type (2016-2027)
6.3 North America Esophageal Cancer Drugs Market Size by Application
6.3.1 North America Esophageal Cancer Drugs Market Size by Application (2016-2021)
6.3.2 North America Esophageal Cancer Drugs Market Size by Application (2022-2027)
6.3.3 North America Esophageal Cancer Drugs Market Size by Application (2016-2027)
6.4 North America Esophageal Cancer Drugs Market Size by Country
6.4.1 North America Esophageal Cancer Drugs Market Size by Country (2016-2021)
6.4.2 North America Esophageal Cancer Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Esophageal Cancer Drugs Market Size (2016-2027)
7.2 Europe Esophageal Cancer Drugs Market Size by Type
7.2.1 Europe Esophageal Cancer Drugs Market Size by Type (2016-2021)
7.2.2 Europe Esophageal Cancer Drugs Market Size by Type (2022-2027)
7.2.3 Europe Esophageal Cancer Drugs Market Size by Type (2016-2027)
7.3 Europe Esophageal Cancer Drugs Market Size by Application
7.3.1 Europe Esophageal Cancer Drugs Market Size by Application (2016-2021)
7.3.2 Europe Esophageal Cancer Drugs Market Size by Application (2022-2027)
7.3.3 Europe Esophageal Cancer Drugs Market Size by Application (2016-2027)
7.4 Europe Esophageal Cancer Drugs Market Size by Country
7.4.1 Europe Esophageal Cancer Drugs Market Size by Country (2016-2021)
7.4.2 Europe Esophageal Cancer Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Esophageal Cancer Drugs Market Size (2016-2027)
8.2 Asia-Pacific Esophageal Cancer Drugs Market Size by Type
8.2.1 Asia-Pacific Esophageal Cancer Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Esophageal Cancer Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Esophageal Cancer Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Esophageal Cancer Drugs Market Size by Application
8.3.1 Asia-Pacific Esophageal Cancer Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Esophageal Cancer Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Esophageal Cancer Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Esophageal Cancer Drugs Market Size by Region
8.4.1 Asia-Pacific Esophageal Cancer Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Esophageal Cancer Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Esophageal Cancer Drugs Market Size (2016-2027)
9.2 Latin America Esophageal Cancer Drugs Market Size by Type
9.2.1 Latin America Esophageal Cancer Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Esophageal Cancer Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Esophageal Cancer Drugs Market Size by Type (2016-2027)
9.3 Latin America Esophageal Cancer Drugs Market Size by Application
9.3.1 Latin America Esophageal Cancer Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Esophageal Cancer Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Esophageal Cancer Drugs Market Size by Application (2016-2027)
9.4 Latin America Esophageal Cancer Drugs Market Size by Country
9.4.1 Latin America Esophageal Cancer Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Esophageal Cancer Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Esophageal Cancer Drugs Market Size (2016-2027)
10.2 Middle East & Africa Esophageal Cancer Drugs Market Size by Type
10.2.1 Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Esophageal Cancer Drugs Market Size by Application
10.3.1 Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Esophageal Cancer Drugs Market Size by Country
10.4.1 Middle East & Africa Esophageal Cancer Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Esophageal Cancer Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2016-2021)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Esophageal Cancer Drugs Introduction
11.2.4 Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Introduction
11.4.4 Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Esophageal Cancer Drugs Introduction
11.5.4 Sanofi Revenue in Esophageal Cancer Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Esophageal Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluorouracil
Table 3. Key Players of Cisplatin
Table 4. Key Players of Docetaxel
Table 5. Key Players of Carboplatin
Table 6. Key Players of Others
Table 7. Global Esophageal Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Esophageal Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Esophageal Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Esophageal Cancer Drugs Market Share by Regions (2016-2021)
Table 11. Global Esophageal Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Esophageal Cancer Drugs Market Share by Regions (2022-2027)
Table 13. Esophageal Cancer Drugs Market Trends
Table 14. Esophageal Cancer Drugs Market Drivers
Table 15. Esophageal Cancer Drugs Market Challenges
Table 16. Esophageal Cancer Drugs Market Restraints
Table 17. Global Esophageal Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Esophageal Cancer Drugs Market Share by Players (2016-2021)
Table 19. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2020)
Table 20. Ranking of Global Top Esophageal Cancer Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Esophageal Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Esophageal Cancer Drugs Product Solution and Service
Table 24. Date of Enter into Esophageal Cancer Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Esophageal Cancer Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Esophageal Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Esophageal Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Esophageal Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Esophageal Cancer Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Esophageal Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Esophageal Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Esophageal Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Esophageal Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Esophageal Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Esophageal Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Esophageal Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Esophageal Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Esophageal Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Esophageal Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Esophageal Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Esophageal Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Esophageal Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Esophageal Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Esophageal Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Esophageal Cancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Esophageal Cancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Esophageal Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Esophageal Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Esophageal Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Esophageal Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Esophageal Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Esophageal Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Esophageal Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Esophageal Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Esophageal Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Company Details
Table 65. Bristol-Myers Squibb Company Business Overview
Table 66. Bristol-Myers Squibb Company Esophageal Cancer Drugs Product
Table 67. Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2016-2021) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Recent Development
Table 69. Eli Lilly and Company Company Details
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Esophageal Cancer Drugs Product
Table 72. Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly and Company Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Merck & Co., Inc. Company Details
Table 80. Merck & Co., Inc. Business Overview
Table 81. Merck & Co., Inc. Esophageal Cancer Drugs Product
Table 82. Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2016-2021) & (US$ Million)
Table 83. Merck & Co., Inc. Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Esophageal Cancer Drugs Product
Table 87. Sanofi Revenue in Esophageal Cancer Drugs Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Esophageal Cancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. Fluorouracil Features
Figure 3. Cisplatin Features
Figure 4. Docetaxel Features
Figure 5. Carboplatin Features
Figure 6. Others Features
Figure 7. Global Esophageal Cancer Drugs Market Share by Application: 2020 VS 2027
Figure 8. Targeted Therapy Case Studies
Figure 9. Chemotherapy Case Studies
Figure 10. Esophageal Cancer Drugs Report Years Considered
Figure 11. Global Esophageal Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Esophageal Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Esophageal Cancer Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Esophageal Cancer Drugs Market Share by Regions (2022-2027)
Figure 15. Global Esophageal Cancer Drugs Market Share by Players in 2020
Figure 16. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Esophageal Cancer Drugs Revenue in 2020
Figure 18. Global Esophageal Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Esophageal Cancer Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Esophageal Cancer Drugs Market Share by Type (2016-2027)
Figure 22. North America Esophageal Cancer Drugs Market Share by Application (2016-2027)
Figure 23. North America Esophageal Cancer Drugs Market Share by Country (2016-2027)
Figure 24. United States Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Esophageal Cancer Drugs Market Share by Type (2016-2027)
Figure 28. Europe Esophageal Cancer Drugs Market Share by Application (2016-2027)
Figure 29. Europe Esophageal Cancer Drugs Market Share by Country (2016-2027)
Figure 30. Germany Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Esophageal Cancer Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Esophageal Cancer Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Esophageal Cancer Drugs Market Share by Region (2016-2027)
Figure 40. China Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Esophageal Cancer Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Esophageal Cancer Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Esophageal Cancer Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Esophageal Cancer Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Esophageal Cancer Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Esophageal Cancer Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Esophageal Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol-Myers Squibb Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2016-2021)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Esophageal Cancer Drugs Business (2016-2021)
Figure 62. Merck & Co., Inc. Revenue Growth Rate in Esophageal Cancer Drugs Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Esophageal Cancer Drugs Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---